11 series
Export
<<<Page of 1 >>>
Accession Title Series type(s) Organism(s) Samples GDS Supplementary Contact Release date
Remove filtersFilter Remove filterGiuseppe Testa
GSE63057
7q11.23 dosage-dependent dysregulation in the human pluripotent state primes aberrant transcriptional programs in disease-relevant lineages (ChIP-Seq)
22 Giuseppe Testa Dec 15, 2014
GSE63058
7q11.23 dosage-dependent dysregulation in the human pluripotent state primes aberrant transcriptional programs in disease-relevant lineages
139 Giuseppe Testa Dec 15, 2014
GSE120635
KMT2B is selectively required for neuronal transdifferentiation [ChIP-seq]
47 Giuseppe Testa Sep 29, 2018
GSE63028
7q11.23 dosage-dependent dysregulation in the human pluripotent state primes aberrant transcriptional programs in disease-relevant lineages (aCGH)
34 Giuseppe Testa Dec 15, 2014
GSE63040
7q11.23 dosage-dependent dysregulation in the human pluripotent state primes aberrant transcriptional programs in disease-relevant lineages (microarray)
26 Giuseppe Testa Dec 15, 2014
GSE120440
KMT2B is selectively required for neuronal transdifferentiation [RNAseq]
16 Giuseppe Testa Sep 26, 2018
GSE63055
7q11.23 dosage-dependent dysregulation in the human pluripotent state primes aberrant transcriptional programs in disease-relevant lineages (RNAseq)
57 Giuseppe Testa Dec 15, 2014
GSE98476
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq]
18 Giuseppe Testa May 19, 2017
GSE98477
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [ChIP-seq]
38 Giuseppe Testa May 19, 2017
GSE98478
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction.
56 Giuseppe Testa May 19, 2017
GSE120441
KMT2B is selectively required for neuronal transdifferentiation
16 Giuseppe Testa Sep 26, 2018